NCLEX Questions With Rationales / Pharmacology / Drug Classes & Mechanisms
NCLEX Questions With Rationales

Metformin NCLEX Questions With Rationales

Pharmacology · Drug Classes & Mechanisms·Updated 2026-11-19

What it is

Metformin is an oral biguanide medication used with diet and exercise to improve blood glucose control in clients with type 2 diabetes mellitus. It primarily decreases hepatic glucose production and improves insulin sensitivity, increasing peripheral glucose utilization. When used alone, metformin generally does not cause hypoglycemia because it does not directly stimulate pancreatic insulin secretion.

What the NCLEX focuses on

  • Mechanism of action: Metformin reduces glucose production in the liver and improves the body's response to insulin, helping lower fasting and postmeal blood glucose.
  • Administration: Immediate-release tablets are generally taken with meals to reduce gastrointestinal adverse effects. Extended-release formulations are commonly taken with the evening meal according to the specific product instructions.
  • Common adverse effects: Nausea, diarrhea, abdominal discomfort, bloating, and a metallic taste may occur, particularly when treatment is initiated or the dose is increased.
  • Hypoglycemia: Metformin used alone has a low risk of hypoglycemia. However, hypoglycemia can occur when it is combined with insulin or other glucose-lowering medications.
  • Lactic acidosis: This rare but potentially fatal complication is associated with metformin accumulation and impaired lactate clearance, particularly in clients with renal impairment, hypoxia, hepatic impairment, or excessive alcohol intake.
  • Warning symptoms: Unusual weakness, muscle pain, abdominal discomfort, respiratory distress, unusual sleepiness, and feeling generally unwell may indicate lactic acidosis and require immediate medical evaluation.
  • Renal function: Assess estimated glomerular filtration rate (eGFR) before starting therapy and periodically during treatment. Metformin is contraindicated when eGFR is below 30 mL/min/1.73 m².
  • Starting metformin is not recommended when eGFR is between 30 and 45 mL/min/1.73 m². If eGFR falls below 45 during treatment, reassess the benefits and risks of continuing therapy.
  • Iodinated contrast: Temporarily discontinue metformin at or before contrast administration in clients with eGFR between 30 and 60 mL/min/1.73 m², a history of liver disease, alcoholism or heart failure, or those receiving intra-arterial contrast. Reassess renal function after 48 hours and restart if renal function is stable.
  • Vitamin B12: Long-term metformin therapy can reduce vitamin B12 absorption and cause deficiency, potentially contributing to anemia and peripheral neuropathy.
  • Surgery and acute illness: Temporary interruption may be necessary during surgery, prolonged fasting, dehydration, severe infection, or conditions associated with hypoxia or acute kidney injury. Follow the provider's instructions.
  • Alcohol: Excessive alcohol consumption increases the risk of metformin-associated lactic acidosis and should be avoided.

Priority nursing actions

  • Assess blood glucose, medication history, renal function, hydration status, and relevant comorbidities before administration.
  • Administer immediate-release metformin with meals and follow formulation-specific instructions for extended-release tablets.
  • Monitor renal function periodically and report declining eGFR or conditions that increase the risk of lactic acidosis.
  • Hold metformin when indicated for iodinated contrast studies, surgery, or acute illness, and verify when it is safe to restart.
  • Assess for persistent gastrointestinal symptoms, unusual fatigue, muscle pain, respiratory distress, and possible vitamin B12 deficiency.
  • When metformin is combined with insulin, monitor blood glucose and observe for hypoglycemia.

Numbers to know

ValueNumberWhy it matters
Contraindicated renal functioneGFR below 30 mL/min/1.73 m²Metformin must not be used at this level of renal impairment.
Do not initiate treatmenteGFR 30 to 45 mL/min/1.73 m²Initiation is not recommended in this range.
Reassess continuationeGFR below 45 mL/min/1.73 m²Evaluate the risks and benefits of continued treatment.
Contrast-related renal reassessment48 hoursReassess renal function before restarting when interruption is required.
Metformin-associated lactic acidosisLactate above 5 mmol/LA characteristic laboratory finding associated with lactic acidosis.
Vitamin B12 monitoringEvery 2 to 3 years in long-term users, or sooner when indicatedConsider periodic assessment for deficiency, especially with anemia or neuropathy.

Common exam traps

  • Choosing metformin for a client with eGFR below 30 mL/min/1.73 m²: wrong because severe renal impairment is a contraindication.
  • Choosing administration on an empty stomach: wrong because taking immediate-release metformin with meals reduces gastrointestinal adverse effects.
  • Choosing to restart metformin immediately after iodinated contrast: wrong because renal function must be reassessed after 48 hours when interruption is indicated.
  • Choosing to ignore unexplained muscle pain and respiratory distress: wrong because these symptoms may indicate life-threatening lactic acidosis.
  • Choosing to assume metformin alone commonly causes hypoglycemia: wrong because it does not directly stimulate insulin secretion.

What to teach

  • Take metformin with meals according to the prescribed formulation and do not crush extended-release tablets unless the product specifically permits it.
  • Continue recommended nutrition, physical activity, blood glucose monitoring, and follow-up appointments.
  • Report severe weakness, muscle pain, unusual sleepiness, abdominal discomfort, or difficulty breathing immediately.
  • Inform the health care team before imaging procedures involving iodinated contrast or planned surgery.
  • Avoid excessive alcohol consumption and maintain adequate hydration, especially during illness.
  • Attend recommended vitamin B12 and kidney function monitoring appointments.

2 NCLEX questions with rationales on this topic

From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.

Question 1 · QID AA53526F

A client taking metformin is scheduled for a computed tomography scan with intravenous contrast dye. Which action should the nurse anticipate?

Select the best answer.

  1. A. Continue metformin through the scan without a renal check
  2. B. Discontinue metformin permanently and convert to insulin
  3. C. Double the morning metformin dose before the scan
  4. D. Hold the metformin around the procedure per protocol
Show the correct answer and rationale

Correct answer:

  • D. Hold the metformin around the procedure per protocol

Rationale

Overview

  • Definition: Metformin management around iodinated contrast follows renal-function and procedure-specific criteria.
  • Why lactic acidosis: Acute kidney injury reduces metformin clearance. Drug accumulation increases the risk of lactic acidosis.
  • Hold and restart rule: When protocol criteria require withholding, stop at or before contrast administration. Reassess renal function after 48 hours and restart only when stable.

Nursing key points

  • Review estimated glomerular filtration rate and acute kidney injury status.
  • Apply the facility's contrast protocol; IV contrast alone does not require a hold for every client.
  • FDA labeling requires a hold for eGFR 30 to 60 mL/min/1.73 m2 or specified additional risk factors.
  • When withheld, reassess renal function after 48 hours before restarting.
  • Monitor glucose during the interruption and obtain prescribed treatment instructions.

Answer analysis

Anticipated actionRationale
Continue metformin through the scan without a renal checkNot correct. Renal assessment determines safe contrast-related management.
Discontinue metformin permanently and convert to insulinNot correct. A temporary procedural interruption does not require permanent insulin therapy.
Double the morning metformin dose before the scanNot correct. Doubling provides no procedural benefit and increases adverse-effect risk.
Hold the metformin around the procedure per protocolCorrect. Follow protocol criteria for withholding and renal reassessment before restarting.
Question 2 · QID DBC37672

The nurse teaches a client newly started on metformin. Which teaching points should the nurse include? Select all that apply.

  1. A. Carry a fast-acting carbohydrate at all times because of high hypoglycemia risk
  2. B. Tell every provider you take this before any procedure using contrast dye
  3. C. This medication alone is unlikely to cause hypoglycemia
  4. D. Stop the medication permanently if mild nausea occurs in the first week
  5. E. Take it with food to reduce stomach upset
  6. F. Report unusual muscle pain, weakness, or difficulty breathing
Show the correct answer and rationale

Correct answers:

  • B. Tell every provider you take this before any procedure using contrast dye
  • C. This medication alone is unlikely to cause hypoglycemia
  • E. Take it with food to reduce stomach upset
  • F. Report unusual muscle pain, weakness, or difficulty breathing

Rationale

Overview

  • Definition: Metformin is a biguanide that lowers hepatic glucose production without stimulating insulin secretion.
  • Expected effects: Hypoglycemia with monotherapy is rare. Early gastrointestinal upset usually subsides.
  • What to report: Muscle pain, weakness, dyspnea, and malaise are warning signs of lactic acidosis.

Nursing key points

  • Take with meals; report persistent gastrointestinal symptoms.
  • Obtain emergency assessment for lactic acidosis symptoms.
  • Disclose metformin before contrast procedures; follow risk-based holding instructions.
  • Stop for eGFR below 30 mL/min/1.73 m²; contact the prescriber.
  • Follow ordered vitamin B12 testing; review deficiency risk yearly.

Answer analysis

Teaching pointRationale
Carry a fast-acting carbohydrate at all times because of high hypoglycemia riskNot correct. Metformin alone has low hypoglycemia risk.
Tell every provider you take this before any procedure using contrast dyeCorrect. Disclosure permits renal assessment and appropriate temporary withholding.
This medication alone is unlikely to cause hypoglycemiaCorrect. Metformin does not directly stimulate insulin release.
Stop the medication permanently if mild nausea occurs in the first weekNot correct. Mild initial nausea does not require permanent discontinuation.
Take it with food to reduce stomach upsetCorrect. Food reduces gastrointestinal discomfort.
Report unusual muscle pain, weakness, or difficulty breathingCorrect. These symptoms require urgent assessment for lactic acidosis.
Want more questions on this topic?

The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.

Create Account →

More topics in Pharmacology

Proton Pump Inhibitors and Antacids NCLEX Questions With RationalesReviews acid-suppressing medications, administration, adverse effects, drug interactions, and nursing priorities for gastrointestinal bleeding.Calcium Channel Blockers NCLEX Questions With RationalesReviews calcium channel blocker classes, cardiovascular uses, adverse effects, nursing assessments, medication safety, and client teaching.Statins NCLEX Questions With RationalesReviews statin medications, LDL reduction, adverse effects, drug interactions, laboratory monitoring, and client education.
Practice the NCLEX questions on this topic

3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.

Create Account →